Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.69 |
| ▸ | CA1 | P00915 | 3/20 | 0.69 |
| ▸ | CA9 | Q16790 | 3/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.66 |
| ▸ | RAB9A | P51151 | 6/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.62 |
| ▸ | NPC1 | O15118 | 5/20 | 0.62 |
| ▸ | HPGD | P15428 | 4/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.62 |
| ▸ | GAA | P10253 | 2/20 | 0.60 |
| ▸ | GLA | P06280 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22882751 | 1.00 | CA12 (0.69) | CA12CA1CA9TDP1RAB9A | |
| SCHEMBL29543774 | 1.00 | CA12 (0.69) | CA12CA1CA9TDP1RAB9A | |
| Hydrochloric Acid SCHEMBL29402049 | 0.99 | CA12 (0.67) | CA12CA1CA9TDP1RAB9A | |
| Trifluoroacetic Acid SCHEMBL592896 | 0.92 | TDP1 (0.61) | CA12CA1CA9TDP1RAB9A | |
| SCHEMBL29536174 | 0.90 | CA12 (0.66) | CA12CA1CA9TDP1RAB9A | |
| SCHEMBL14176759 | 0.89 | CA12 (0.72) | CA12CA1CA9TDP1RAB9A | |
| SCHEMBL29544277 | 0.89 | CA12 (0.64) | CA12CA1CA9TDP1RAB9A | |
| SCHEMBL5706432 | 0.87 | CA12 (0.62) | CA12CA1CA9TDP1RAB9A | |
| SCHEMBL29543713 | 0.87 | CA12 (0.62) | CA12CA1CA9TDP1RAB9A | |
| SCHEMBL571384 | 0.87 | CA12 (0.62) | CA12CA1CA9TDP1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5064756-A | MICROBIAL SUSCEPTIBILITY ASSAY USING 7-N-(AMINOACYL)-7-AMIDO-4-METHYLCOUMARINS | SIEMENS HEALTHCARE DIAGNOSTICS INC. | 1991-11-12 | — | — | US | claimed |
| WO-1983003624-A1 | MICROBIOLOGICAL TEST PROCESSES AND APPARATUS | UNILEVER PLC (GB) | 1983-10-27 | — | — | WO | claimed |
| EP-4196181-A1 | MOVING-FRONT STERILIZATION MONITORING DEVICES | 3M Innovative Properties Company (US) | 2023-06-21 | — | — | EP | disclosed |
| US-11667945-B2 | Detection method and detection probe for colibactin and colibactin-producing bacteria | SHIZUOKA PREFECTURE PUBLIC UNIVERSITY CORPORATION (JP) | 2023-06-06 | — | — | US | disclosed |
| WO-2022263950-A1 | BIOLOGICAL INDICATOR WITH ADJUSTED RESISTANCE CHARACTERISTICS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-12-22 | — | — | WO | disclosed |
| WO-2022034498-A1 | MOVING-FRONT STERILIZATION MONITORING DEVICES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-02-17 | — | — | WO | disclosed |
| US-20210010051-A1 | DETECTION METHOD AND DETECTION PROBE FOR COLIBACTIN AND COLIBACTIN-PRODUCING BACTERIA | SHIZUOKA PREFECTURE PUBLIC UNIVERSITY CORPORATION (JP) | 2021-01-14 | — | — | US | disclosed |
| EP-2877591-B1 | METHOD OF DETECTING OXA-048 CARBAPENEMASE PRODUCING BACTERIA | BIOMERIEUX SA (FR) | 2018-01-10 | — | — | EP | disclosed |
| US-9562899-B2 | Method of detecting OXA-048 carbapenemase producing bacteria | bioMérieux (FR) | 2017-02-07 | — | — | US | disclosed |
| US-20150160211-A1 | METHOD OF DETECTING OXA-048 CARBAPENEMASE PRODUCING BACTERIA | BIOMERIEUX (FR) | 2015-06-11 | — | — | US | disclosed |
| EP-2877591-A1 | METHOD OF DETECTING OXA-048 CARBAPENEMASE PRODUCING BACTERIA | Biomérieux (FR) | 2015-06-03 | — | — | EP | disclosed |
| EP-0516814-A1 | METHOD AND COMPOSITION FOR DETERMINING ANTIMICROBIAL SUSCEPTIBILITY OF THE MAJORITY OF CLINICALLY SIGNIFICANT GRAM POSITIVE ORGANISMS. | BAXTER DIAGNOSTICS INC (US) | 1992-12-09 | — | — | EP | disclosed |
| WO-1992012257-A1 | METHOD AND COMPOSITION FOR DETERMINING ANTIMICROBIAL SUSCEPTIBILITY OF THE MAJORITY OF CLINICALLY SIGNIFICANT GRAM POSITIVE ORGANISMS | BAXTER DIAGNOSTICS INC. (US) | 1992-07-23 | — | — | WO | disclosed |
| US-5079144-A | Test For Antibiotic Sensitivity Or For Minimum Inhibitory Concentration Of The Antibiotic | RADIOMETER CORPORATE DEVELOPMENT LTD. (GB) | 1992-01-07 | — | — | US | disclosed |
| US-5064756-A | MICROBIAL SUSCEPTIBILITY ASSAY USING 7-N-(AMINOACYL)-7-AMIDO-4-METHYLCOUMARINS | SIEMENS HEALTHCARE DIAGNOSTICS INC. | 1991-11-12 | — | — | US | disclosed |
| US-5064756-A | MICROBIAL SUSCEPTIBILITY ASSAY USING 7-N-(AMINOACYL)-7-AMIDO-4-METHYLCOUMARINS | SIEMENS HEALTHCARE DIAGNOSTICS INC. | 1991-11-12 | — | — | US | disclosed |
| EP-0335354-A2 | Rapid and sensitive low pressure enzyme detection and measurement system | BioControl Systems, Incorporated (US) | 1989-10-04 | — | — | EP | disclosed |
| EP-0091837-B1 | MICROBIOLOGICAL TEST PROCESSES AND APPARATUS | RADIOMETER CORPORATE DEVELOPMENT LIMITED (GB) | 1989-07-26 | — | — | EP | disclosed |
| WO-1983003624-A1 | MICROBIOLOGICAL TEST PROCESSES AND APPARATUS | UNILEVER PLC (GB) | 1983-10-27 | — | — | WO | disclosed |
| EP-0091837-A1 | Microbiological test processes and apparatus | RADIOMETER CORPORATE DEVELOPMENT LIMITED (GB) | 1983-10-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210010051-A1 | DETECTION METHOD AND DETECTION PROBE FOR COLIBACTIN AND COLIBACTIN-PRODUCING BACTERIA | CLTB, LNPEP, CMBL | CA12 1318/4885CA1 2181/4885CA9 2947/4885 |
| US-11667945-B2 | Detection method and detection probe for colibactin and colibactin-producing bacteria | CLTB, LNPEP, CMBL | CA12 1318/4885CA1 2181/4885CA9 2947/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.